Los Angeles Cancer Network — Glendale, California

Los Angeles Cancer Network is a clinical research site located in Glendale, California, United States 91204.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Los Angeles Cancer Network has participated in 11 clinical trials with 11 currently active.

Therapeutic areas: Colorectal Neoplasms, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Hepatocellular Carcinoma (HCC).

Sponsors: Janssen Research & Development, LLC, Pfizer, Shanghai Henlius Biotech.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Los Angeles Cancer Network?

Los Angeles Cancer Network has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Los Angeles Cancer Network conducted?

Los Angeles Cancer Network has 11 clinical trials on record, with 11 currently active. Their work covers Colorectal Neoplasms, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Hepatocellular Carcinoma (HCC).

Is Los Angeles Cancer Network accredited by Crixeo Health?

Yes — Los Angeles Cancer Network holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Los Angeles Cancer Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.